✦ LIBER ✦

Inhibition of Angiogenesis for the Treatment of Metastatic Melanoma

✍ Scribed by Mansfield, Aaron S.; Markovic, Svetomir N.

Book ID: 125376068
Publisher: Current Science Inc.
Year: 2013
Tongue: English
Weight: 192 KB
Volume: 15
Category: Article
ISSN: 1523-3790
DOI: 10.1007/s11912-013-0334-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of Angiogenesis: Treatment Op

Inhibition of Angiogenesis: Treatment Options for Patients with Metastatic Prostate Cancer

✍ William D. Figg; Erwin A. Kruger; Douglas K. Price; Sonia Kim; William D. Dahut 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 146 KB

Targeting angiogenesis for the treatment

Targeting angiogenesis for the treatment of advanced melanoma

✍ Dimitrios J. Bafaloukos; Helena Linardou 📂 Article 📅 2011 🏛 PAGEPress Publications 🌐 English ⚖ 270 KB

Vemurafenib and BRAF Inhibition: A New C

Vemurafenib and BRAF Inhibition: A New Class of Treatment for Metastatic Melanoma

✍ Luke, J. J.; Hodi, F. S. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 568 KB

Upcoming strategies for the treatment of

Upcoming strategies for the treatment of metastatic melanoma

✍ Francesco Spagnolo; Paola Queirolo 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 164 KB

Systemic chemotherapy for the treatment

Systemic chemotherapy for the treatment of metastatic melanoma

✍ Yan Li; Edward F McClay 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Systemic chemotherapy for the treatment

Systemic chemotherapy for the treatment of metastatic melanoma

✍ Yan Li; Edward F McClay 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 118 KB

The role of systemic chemotherapy in the treatment of patients with metastatic melanoma remains of questionable benefit. Despite encouraging phase II data from multiple institutions that suggested an improved overall response rate for patients treated with the Dartmouth regimen, recently completed p